Literature DB >> 25692808

Acute, nonvariceal upper gastrointestinal bleeding.

Amir Klein1, Ian M Gralnek.   

Abstract

PURPOSE OF REVIEW: Acute, nonvariceal upper gastrointestinal bleeding (UGIB) is a common medical emergency encountered worldwide. Despite medical and technological advances, it remains associated with significant morbidity and mortality. RECENT
FINDINGS: Rapid patient assessment and management are paramount. When indicated, upper endoscopy in patients presenting with acute UGIB is effective for both diagnosis of the bleeding site and provision of endoscopic hemostasis. Endoscopic hemostasis significantly reduces rebleeding rates, blood transfusion requirements, length of hospital stay, surgery, and mortality. Furthermore, early upper endoscopy, defined as being performed within 24 h of patient presentation, improves patient outcomes.
SUMMARY: A structured approach to the patient with acute UGIB that includes early hemodynamic resuscitation and stabilization, preendoscopic risk stratification using validated instruments, pharmacologic and endoscopic intervention, and postendoscopy therapy is important to optimize patient outcome and assure efficient use of medical resources.

Entities:  

Mesh:

Year:  2015        PMID: 25692808     DOI: 10.1097/MCC.0000000000000185

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  6 in total

1.  Alcohol Abuse Increases Rebleeding Risk and Mortality in Patients with Non-variceal Upper Gastrointestinal Bleeding.

Authors:  Jussi M Kärkkäinen; Sami Miilunpohja; Tuomo Rantanen; Jenni M Koskela; Johanna Jyrkkä; Juha Hartikainen; Hannu Paajanen
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

2.  Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.

Authors:  Borja Ruiz; Urko Aguirre; Ana Estany-Gestal; Luca Rodella; Pablo Ruiz; Adolfo Figueiras; Alfonso Carvajal; Luisa Ibáñez; Anita Conforti; Marian M de Pancorbo; Xavier Vidal; Luis H Martin; Carmelo Aguirre
Journal:  Eur J Clin Pharmacol       Date:  2018-07-24       Impact factor: 2.953

3.  NSAID, antiaggregant, and/or anticoagulant-related upper gastrointestinal bleeding: Is there any change in prophylaxis rate after a 10-year period?

Authors:  Dinç Dinçer; Ece Ulukal Karancı; Mete Akın; Haydar Adanır
Journal:  Turk J Gastroenterol       Date:  2019-06       Impact factor: 1.852

4.  Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects.

Authors:  Yue-Qi Li; Zheng-Yu Yan; Hong-Wen Zhang; Lu-Ning Sun; Hui-Wen Jiao; Mei-Feng Wang; Li-Yuan Yu; Lei Yu; Zi-Qing-Yun Yuan; Ling Meng; Yong-Qing Wang
Journal:  Eur J Clin Pharmacol       Date:  2017-01-31       Impact factor: 2.953

5.  Clinical Outcomes of Endoscopic Hemostasis for Bleeding in Patients with Unresectable Advanced Gastric Cancer.

Authors:  In Ji Song; Hyun Ju Kim; Ji Ae Lee; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Hyunsoo Chung
Journal:  J Gastric Cancer       Date:  2017-12-27       Impact factor: 3.720

6.  Correlation between the Glasgow-Blatchford score, shock index, and Forrest classification in patients with peptic ulcer bleeding

Authors:  Hong Yang; Chen Pan; Qi Liu; Yan Wang; Zhe Liu; Xian Cao; Jingjing Lei
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.